Pfizer (PFE) resumed with a Neutral at BofA/Merrill; target $37
Merck (MRK) resumed with a Neutral at BofA/Merrill; target $90
By clicking "OK" you are providing your consent to our use of cookies. For more information, please read our Privacy Policy